The geoepidemiology of the antiphospholipid antibody syndrome

scientific article

The geoepidemiology of the antiphospholipid antibody syndrome is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AUTREV.2009.11.013
P698PubMed publication ID19932199
P5875ResearchGate publication ID40025560

P50authorMartina BiggioggeroQ60319740
Pier Luigi MeroniQ38544871
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
P304page(s)A299-304
P577publication date2009-11-25
P1433published inAutoimmunity ReviewsQ15754966
P1476titleThe geoepidemiology of the antiphospholipid antibody syndrome
P478volume9

Reverse relations

cites work (P2860)
Q38692085'To test or not to test', the arguments for and against thrombophilia testing in obstetrics
Q46857664Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus
Q48020789Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies
Q41737006Anti-phospholipid antibodies in patients undergoing total joint replacement surgery
Q90312463Antiphospholipid Antibodies: From General Concepts to Its Relation with Malignancies
Q89810829Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study
Q90312460Antiphospholipid Syndrome and Kidney Involvement: New Insights
Q41808505Antiphospholipid antibodies and systemic scleroderma
Q36923241Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.
Q64046338Antiphospholipid syndrome
Q37228076Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study
Q39502759Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis
Q34024573Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome?
Q33825348Autoimmunity and environment: am I at risk?
Q37212291Behçet's Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity?
Q37841101Celiac disease: a model disease for gene-environment interaction
Q36159957Clinical and laboratory characteristics of children positive for antiphospholipid antibodies
Q34659598Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
Q42130326Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome.
Q45959876Cutting-edge issues in organ-specific autoimmunity.
Q92244140Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman
Q38805695Does APS Impact Women's Fertility?
Q28390922Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop
Q42558630Explosion of autoimmune diseases and the mosaic of old and novel factors
Q45932087Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.
Q50041259Immunological Rare Diseases
Q64043321Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology
Q37704874Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome
Q35907083LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers
Q51332462Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome.
Q83082263Mechanisms and pathophysiology of autoimmune disease
Q39298598Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function.
Q38891094Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Q40838962Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study
Q41980805Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report
Q51065284Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
Q45245990Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors
Q26775647Sarcoidosis and Antiphospholipid Syndrome: A Systematic Review of Cases
Q64951272Study of Antiphospholipid Antibodies in Patients with Arterial Hypertension.
Q33394044Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations
Q84974441The Persistent Challenge of Lupus Nephritis
Q38873953The antiphospholipid syndrome: from pathophysiology to treatment.
Q98945626The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria
Q43786536The future of autoimmunity
Q34402456The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome
Q26866133The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome
Q37967566The therapeutic potential of epigenetics in autoimmune diseases.
Q33443797Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study
Q38258585Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome
Q90312426β2GP1, Anti-β2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome

Search more.